SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-030475
Filing Date
2024-03-04
Accepted
2024-03-04 16:03:37
Documents
19
Period of Report
2024-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247888d1_8k.htm   iXBRL 8-K 28217
2 EXHIBIT 10.1 tm247888d1_ex10-1.htm EX-10.1 397548
3 EXHIBIT 10.2 tm247888d1_ex10-2.htm EX-10.2 37685
4 EXHIBIT 10.3 tm247888d1_ex10-3.htm EX-10.3 37804
5 EXHIBIT 99.1 tm247888d1_ex99-1.htm EX-99.1 10566
9 GRAPHIC image_001.jpg GRAPHIC 2408
  Complete submission text file 0001104659-24-030475.txt   800638

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA armp-20240304.xsd EX-101.SCH 3027
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20240304_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20240304_pre.xml EX-101.PRE 22367
20 EXTRACTED XBRL INSTANCE DOCUMENT tm247888d1_8k_htm.xml XML 3482
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 24714942
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)